Filters close
Released: 6-Sep-2017 3:15 PM EDT
Honeybees Could Play a Role in Developing New Antibiotics
University of Illinois Chicago

An antimicrobial compound made by honeybees could become the basis for new antibiotics, according to new research at the University of Illinois at Chicago.

   
Released: 6-Sep-2017 3:15 PM EDT
The Medical Minute: Helping Children Thrive After Cancer
Penn State Health

Childhood cancer survivors are at a higher risk of developing physical and emotional difficulties once their treatment is complete. That's why it’s important to connect them with follow-up care and resources.

Released: 6-Sep-2017 3:05 PM EDT
Human Genetics Studies Reveal New Targets to Reduce Heart Disease
Perelman School of Medicine at the University of Pennsylvania

Again and again, it’s the rare among humans that help the rest of us. The exploration of human genetics is revealing new targets to combat heart disease among atypical variants. Mutations in genes that play a role in heart health are the inspiration for a cluster of new heart drugs.

Released: 6-Sep-2017 3:05 PM EDT
Expert Alert: Mayo Clinic Specialists Address Concussion Injuries
Mayo Clinic

There continues to be a lot of discussion about concussions. How much do people really know about how to spot a concussion? What should be done about a concussion? And how are they treated? Many people don’t know how a concussion is caused.

Released: 6-Sep-2017 2:05 PM EDT
New UC San Diego Master’s Degree Will Train Professionals for Drug Development Careers
UC San Diego Health

The Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego now offers a Master of Science in Drug Development and Product Management. This is the pharmacy school’s first master’s degree program. The program is intended for experienced professionals to gain managerial and regulatory knowledge required to lead all aspects of the drug development process, from discovery to clinical application in managed markets.

Released: 6-Sep-2017 2:05 PM EDT
Biosimilars Take Center Stage at 2017 ACR/ARHP Annual Meeting
American College of Rheumatology (ACR)

“Biosimilars: To Switch or Not to Switch?” will be the focus of this year’s Great Debate at the 2017 ACR/ARHP Annual Meeting in San Diego. The debate is scheduled for 2:30 p.m. on Nov. 5 and will feature the perspectives of Dr. Jonathan Kay and Dr. Roy Fleischmann.

Released: 6-Sep-2017 2:05 PM EDT
A Bioactive Molecule May Protect Against Congestive Heart Failure After Heart Attacks
University of Alabama at Birmingham

A form of the fatty acid-derived bioactive molecule called lipoxin improved heart function after a heart attack, as the lipoxin prompted early activation of the resolving phase of the immune response in mice without altering the acute phase.

Released: 6-Sep-2017 2:05 PM EDT
Mercy Medical Center's Dr. Armando Sardi Supports Partners for Cancer Care & Prevention with Annual Golf Tournament
Mercy Medical Center

8th Annual Chipping for Cancer Care and Prevention Golf Tournament, on Friday, Sept. 15th at the Waverly Woods Golf Club in Marriottsville, MD, supports efforts of Partners for Cancer Care and Prevention non-profit organization.

5-Sep-2017 2:30 PM EDT
Synthetic Version of Popular Anticoagulant Poised for Clinical Trials
Rensselaer Polytechnic Institute (RPI)

A synthetic version of low molecular weight heparin is poised for clinical trials and development as a drug for patients with clotting disorders, and those undergoing procedures such as kidney dialysis, heart bypass surgery, stent implantation, and knee and hip replacement.

5-Sep-2017 8:00 AM EDT
Unneeded Medical Care is Common and Driven by Fear of Malpractice, Physician Survey Concludes
Johns Hopkins Medicine

A new national survey of more than 2,000 physicians across multiple specialties finds that physicians believe overtreatment is common and mostly perpetuated by fear of malpractice, as well as patient demand and some profit motives.

Released: 6-Sep-2017 1:05 PM EDT
New Study Finds Improved Vaccine That Protects against Nine Types of HPV is Highly Effective
Moffitt Cancer Center

TAMPA, Fla. – Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations. The advent of human papillomavirus (HPV) vaccines has significantly reduced the number of those who develop and die from cervical cancer.

Released: 6-Sep-2017 1:05 PM EDT
Concussions in Women: Rates, Symptoms and Recovery Are Different
University of California, Los Angeles (UCLA), Health Sciences

Females tend to report more symptoms—and more severe ones--and may also take longer to recover from brain injuries than their male counterparts.

Released: 6-Sep-2017 12:05 PM EDT
Blood Tumor Markers May Warn When Lung Cancer Patients Are Progressing on Targeted Treatments
University of Colorado Cancer Center

University of Colorado Cancer Center study shows that monitoring levels of blood tumor markers may predict when a lung cancer patient is progressing on targeted treatments.

Released: 6-Sep-2017 12:05 PM EDT
Artificial Intelligence Thinks Like People with Autism; Being Used to Develop Educational Tools
Vanderbilt University

Vanderbilt Assistant Professor of Computer Science Maithilee Kunda figured out how to write code that emulates the kind of image-based thinking many people with autism report. The result is a form of artificial intelligence that allows researchers to study a model of human cognition.

   
Released: 6-Sep-2017 11:05 AM EDT
Malaria: Drug Candidate May Reduce Spread of the Parasite
Columbia University Irving Medical Center

Scientists have identified a class of compounds that can block transmission of the parasite that causes malaria and reduce resistance to currently available drugs.

5-Sep-2017 3:35 PM EDT
Common Cerebral White Matter Abnormalities Found in Children with Autistic Traits
NYU Langone Health

Brain imaging study shows white matter structural changes in children correspond to severity of autistic traits.

   
Released: 6-Sep-2017 10:05 AM EDT
New Medical Geneticists Join Ted Rogers Centre for Heart Research
University Health Network (UHN)

The Ted Rogers Centre for Heart Research today announces that Dr. Raymond Kim is its newest scientific lead, guiding efforts at the country’s only clinic devoted to cardiac genomics.

Released: 6-Sep-2017 10:05 AM EDT
WVU Biologists Awarded $1.4 Million Air Force Grant to Examine Moths’ Olfactory Systems
West Virginia University

West Virginia University biologists Kevin Daly and Andrew Dacks are working to uncover the mystery of corollary discharge functions for the sense of smell. Funded by a four year, $1.4 million Air Force grant, Daly and Dacks are studying an animal with one of the most sensitive senses of smell—moths.

   
Released: 6-Sep-2017 10:05 AM EDT
CWRU & University Hospitals physician-researcher Martha Sajatovic, MD Receives International Brain Health Grant, Joins Team in New Diabetes Research Project
Case Western Reserve University

Martha Sajatovic, MD, Professor of Psychiatry and of Neurology at Case Western Reserve University School of Medicine, Willard Brown Chair in Neurological Outcomes Research and Director of the Neurological and Behavioral Outcomes Research Center at University Hospitals Cleveland Medical Center, is the recent recipient of two major research grants.

Released: 6-Sep-2017 10:00 AM EDT
New Generation Drugs May Hold Key to Alternative Erectile Dysfunction Treatment
American Physiological Society (APS)

Close to 70 percent of men with erectile dysfunction (ED) respond to the ED drug sildenafil. However, only about 50 percent of men with diabetes—a population commonly affected by ED—achieve positive results with sildenafil. Researchers from the Smooth Muscle Research Centre at the Dundalk Institute of Technology, in Dundalk, Ireland, are studying two new drugs that may give men with diabetes—and others for whom conventional treatment is ineffective—new hope for treating ED.



close
1.90781